Literature DB >> 33136188

Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.

Susanne N Kolle1, Robert Landsiedel2.   

Abstract

In regulatory toxicology, in vivo studies are still prevailing, and human-derived in vitro models are mostly used in testing for local toxicity to the skin and the eyes. A single in vitro model may be limited to address one or few molecular or cellular events leading to adverse outcomes. Hence, in many instances their regulatory use involves the combination of several in vitro models to assess the hazard potential of test substance. A so-called defined approach combines different testing methods and a 'data interpretation procedure' to obtain a comprehensive overall assessment which is used for the regulatory hazard classification of the test substance.Validation is a prerequisite of regulatory acceptance of new testing methods: This chapter provides an overview of the method development from an experimental method to a test guideline via application of GIVIMP (good in vitro method practice), standardization, validation to the regulatory adoption as an OECD test guidelines. Quandaries associated with the validation towards reference data from in vivo animal studies with limited accuracy and limited human relevance are discussed, as well as uncertainty and limitations arising from restricted applicability and technical and biological variance of the in vitro methods.This chapter provides an overview of human-derived in vitro models currently adopted as OECD test guidelines: From the first skin corrosion tests utilizing reconstructed human epidermis models (RhE), to models to test for skin irritation, phototoxicity, eye irritation, and skin sensitization. The latter is using a battery of different methods and defined approaches which are still under discussion for their regulatory adoption. They will be a vanguard of future applications of human-derived models in regulatory toxicology. RhEs for testing of genotoxicity and of dermal penetration and absorption, have been developed, underwent validation studies and may soon be adopted for regulatory use; these are included in this chapter.

Entities:  

Keywords:  Dermal penetration and absorption; Eye irritation; Genotoxicity; Human-derived model; OECD test guideline; Phototoxicity; Skin corrosion and irritation; Skin sensitization; Uncertainty; Validation

Year:  2021        PMID: 33136188     DOI: 10.1007/164_2020_368

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  33 in total

1.  Putting the parts together: combining in vitro methods to test for skin sensitizing potentials.

Authors:  Caroline Bauch; Susanne N Kolle; Tzutzuy Ramirez; Tobias Eltze; Eric Fabian; Annette Mehling; Wera Teubner; Bennard van Ravenzwaay; Robert Landsiedel
Journal:  Regul Toxicol Pharmacol       Date:  2012-06-01       Impact factor: 3.271

2.  The Phenion full-thickness skin model for percutaneous absorption testing.

Authors:  K Ackermann; S Lombardi Borgia; H C Korting; K R Mewes; M Schäfer-Korting
Journal:  Skin Pharmacol Physiol       Date:  2009-12-14       Impact factor: 3.479

3.  A protocol to determine dermal absorption of xenobiotica through human skin in vitro.

Authors:  Eric Fabian; Franz Oesch; Katharina Ott; Robert Landsiedel; Bennard van Ravenzwaay
Journal:  Arch Toxicol       Date:  2016-07-05       Impact factor: 5.153

Review 4.  International regulatory requirements for skin sensitization testing.

Authors:  Amber B Daniel; Judy Strickland; David Allen; Silvia Casati; Valérie Zuang; João Barroso; Maurice Whelan; M J Régimbald-Krnel; Hajime Kojima; Akiyoshi Nishikawa; Hye-Kyung Park; Jong Kwon Lee; Tae Sung Kim; Isabella Delgado; Ludmila Rios; Ying Yang; Gangli Wang; Nicole Kleinstreuer
Journal:  Regul Toxicol Pharmacol       Date:  2018-03-06       Impact factor: 3.271

5.  An evaluation of selected (Q)SARs/expert systems for predicting skin sensitisation potential.

Authors:  J M Fitzpatrick; D W Roberts; G Patlewicz
Journal:  SAR QSAR Environ Res       Date:  2018-04-20       Impact factor: 3.000

6.  The usefulness of integrated strategy approaches in replacing animal experimentation.

Authors:  Chantra Eskes
Journal:  Ann Ist Super Sanita       Date:  2019 Oct-Dec       Impact factor: 1.663

7.  Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm).

Authors:  Rodger D Curren; Greg C Mun; David P Gibson; Marilyn J Aardema
Journal:  Mutat Res       Date:  2006-06-14       Impact factor: 2.433

8.  Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro.

Authors:  E Fabian; D Vogel; V Blatz; T Ramirez; S Kolle; T Eltze; B van Ravenzwaay; F Oesch; R Landsiedel
Journal:  Arch Toxicol       Date:  2013-09       Impact factor: 5.153

9.  Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate.

Authors:  Franzisca Marie Bätz; Wiebke Klipper; Hans Christian Korting; Frank Henkler; Robert Landsiedel; Andreas Luch; Uwe von Fritschen; Günther Weindl; Monika Schäfer-Korting
Journal:  Eur J Pharm Biopharm       Date:  2012-11-29       Impact factor: 5.571

10.  Describing the validity of carcinogen screening tests.

Authors:  J A Cooper; R Saracci; P Cole
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

View more
  1 in total

1.  Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium.

Authors:  Ivan Rusyn; Courtney Sakolish; Yuki Kato; Clifford Stephan; Leoncio Vergara; Philip Hewitt; Vasanthi Bhaskaran; Myrtle Davis; Rhiannon N Hardwick; Stephen S Ferguson; Jason P Stanko; Piyush Bajaj; Karissa Adkins; Nisha S Sipes; E Sidney Hunter; Maria T Baltazar; Paul L Carmichael; Kritika Sadh; Richard A Becker
Journal:  Toxicol Sci       Date:  2022-07-28       Impact factor: 4.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.